Wednesday 27 May 2020

Latest COVID-19 Research & Evidence — 27/05/20

Title: Mindfulness moments for clinicians in the midst of a pandemic
Description: Drawing on their clinical experience and mindfulness practice, the authors of this paper present a mindfulness tool that may be used by clinicians on the job.
Title: Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and               meta-analysis
Description: This study found that COVID-19 has distinct features in children. Diagnostic features are explored.
Title: The Use of Telepsychiatry During COVID-19 and Beyond
Description:  The COVID-19 pandemic has disrupted the traditional practice of face-to-face psychiatric assessment and treatment. This article discusses the use of telepsychiatry in the context of the COVID-19 pandemic.
Title: Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19
Description: This evidence summary sets out the best available evidence on long-term use of NSAIDs for people with or at risk of COVID-19.
Title: Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19
Description: A summary of the best available evidence on ACEIs or ARBs in people with or at risk of COVID-19.
 
Title: COVID-19 and thrombosis: what do we know about the risks and treatment?
Description: Doctors are seeing high rates of blood clots in patients who are seriously ill with covid-19, but questions remain over best practice, reports Jacqui Wise.
 
Title: Training disrupted: Practical tips for supporting competency-based medical education during the COVID-19 pandemic
Description: Tips provided offer guidance on how to adapt medical education programs during the pandemic.
 
For additional support with accessing the publications above, visit www.wkp.nhs.uk

Disclaimer

The information on here is aimed at keeping the user up-to-date with news and resources available through the library. We take no responsibility for any actions taken due to the content of the site.